Skip to main content
TipRanks
Go Ultimate75% OFF

Cra International (CR2) Q3 2026 Earnings Report

1 Followers

DE:CR2 Q3 2026 EPS Results

Actual EPS
EUR 1.96
Consensus EPS
EUR 1.86
Beat/Miss
Beat by +EUR 0.10
One Year Ago EPS
EUR 1.85

DE:CR2 Q3 2026 Revenue Results

Actual Revenue
EUR 192.74M
Expected Revenue
EUR 178.50M
Beat/Miss
Beat by +EUR 14.24M
YoY Revenue Growth
+15.61%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/05/2026
Time
Before Open
Conference Call
Thursday, November 5, 2026
DE:CR2 Upcoming Earnings

Cra International's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:CR2 Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 05, 2026|% Change Since:2.34%|
Earnings Call Sentiment|Positive

The call was strongly positive overall. CRA reported record quarterly and year-to-date revenue and profitability, broad-based practice growth, more than 20% growth in lead flow and project originations, increased guidance, strong liquidity and continued shareholder returns. The company also cited challenges including a 41% sequential decline in global M&A activity, a higher tax rate, increased amortization expense, higher DSO, foreign-exchange impacts and ongoing macroeconomic and political uncertainty, but these issues did not outweigh the reported operating momentum.

Company Guidance

For full year fiscal 2026, on a constant currency basis relative to fiscal 2025, CRA expects revenue in the range of $830 million to $840 million and non-GAAP EBITDA margin in the range of 12.2% to 12.8%, compared with the prior revenue range of $805 million to $820 million and a prior non-GAAP EBITDA margin range of 12.0% to 13.0%; the constant currency adjustment is expected to decrease CRA's reported revenue by approximately $2.9 million and CRA's reported annual EBITDA by approximately $350,000, including approximately $200,000 of reported revenue impact in the fourth quarter while leaving reported EBITDA unchanged, and noncash forgivable loan amortization is expected to increase in fiscal 2026 by approximately $15 million, including an increase of approximately $1 million during the fourth quarter of fiscal 2026 relative to the fourth quarter of fiscal 2025. Headcount growth for fiscal 2026 will approach mid-single digits; management would not expect or guide investors to the high single digits and is comfortable with the mid-single-digit range.

  • Record Quarterly Revenue and ProfitabilityThird-quarter revenue grew 15.6% year-over-year to $214.9 million, the highest quarterly revenue in CRA's history. Fiscal 2026 has delivered the three highest revenue quarters in the company's history, and Q3 also produced record net income, earnings per diluted share and EBITDA.
  • Broad-Based Practice GrowthSeven practices grew year-over-year, representing approximately 95% of total third-quarter revenue. Forensic Services, Life Sciences and Risk Investigations & Analytics each posted double-digit revenue growth, while Antitrust & Competition Economics, Energy, Forensic Services and Life Sciences each established records for the strongest first nine months of the year.
  • Strong Year-to-Date Financial PerformanceThrough the third quarter, on a constant currency basis relative to fiscal 2025, CRA generated $624 million of revenue and $76.8 million of non-GAAP EBITDA, resulting in a 12.3% margin. Fiscal 2026 has delivered the strongest first nine months for revenue and non-GAAP EBITDA in the company's history.
  • Raised Revenue GuidanceGiven strong year-to-date results and a healthy sales pipeline, CRA increased its fiscal 2026 constant-currency revenue guidance to $830 million to $840 million from the prior range of $805 million to $820 million.
  • Narrowed EBITDA Margin GuidanceFiscal 2026 constant-currency non-GAAP EBITDA margin guidance was narrowed to 12.2% to 12.8% from the prior range of 12.0% to 13.0%.
  • Healthy Sales Pipeline and Project OriginationsAverage weekly project lead flow and new project originations each increased more than 20% year-over-year, continuing the momentum generated during the first half of fiscal 2026.
  • Headcount Growth and Higher UtilizationCRA welcomed approximately 100 new consultants during the quarter. Consulting headcount ended Q3 at 1,028, up 6.2% from 968 a year ago, while consultant utilization increased to 78% from 77%. Management said new colleagues integrated more rapidly than expected.
  • Legal and Regulatory Services Outpaced Market TrendsRevenue from legal and regulatory services increased 15.7%, outpacing broader legal-market trends. Total case filings and court judgments increased year-over-year by 8% and 4%, respectively, excluding the effects of a one-time surge in employment-related case filings.
  • Antitrust Practice Delivered Seventh Straight Record QuarterAntitrust & Competition Economics posted its seventh consecutive record quarter despite global M&A activity declining 41% sequentially in Q3. The practice benefited from ongoing merger-related activity, sustained demand for antitrust services and longer-lived matters.
  • Notable Antitrust Engagements and Case OutcomesCRA advised Paramount Skydance Corporation on its acquisition of Warner Bros. Discovery through the Department of Justice investigation and litigation, with the transaction closing on October 6, 2026. CRA also supported the Canadian Competition Bureau's challenge to Nortera's proposed acquisition of B&G Foods Canada, which the merging parties abandoned, and supported Compass in litigation where the judge denied Zillow's motion for a preliminary injunction citing the CRA expert.
  • Forensic Services Reached a New Quarterly Revenue HighForensic Services set a new high for quarterly revenue while supporting clients on crisis-management matters, including rapidly processing and securely hosting substantial electronically stored information under compressed deadlines and using multiple AI models to identify and test fixes for unknown software vulnerabilities.
  • Risk Investigations and Analytics ActivityThe Risk Investigations and Analytics team worked on several large investigations and damages matters across multiple jurisdictions, including expert assistance regarding controls to prevent asset misappropriation and quantification of economic damages arising from a breach-of-contract and employee-rating matter.
  • Management Consulting GrowthManagement Consulting revenue expanded 9.8% year-over-year, with contributions from the Energy and Life Sciences practices.
  • Energy and Life Sciences EngagementsThe Energy practice advised utilities, data center developers and investors on electricity demand forecasting, data center portfolio assessments, dedicated-generation investments, utility service options, pricing, commercial arrangements, market design and resource adequacy. Life Sciences teams conducted market research in China, France, Germany, the U.K. and the U.S. for a new liver-disease treatment asset.
  • International and North American GrowthInternational operations had grown at more than 20% per annum for approximately the prior four quarters, while North American operations delivered close to 16% year-over-year expansion in Q3. Management said international operations were replenishing staffing capacity and business opportunities.
  • Reduced SG&A RatioNon-GAAP selling, general and administrative expenses, excluding the 1.6% attributable to commissions to nonemployee experts, declined to 14.9% of revenue from 16.3% a year ago.
  • Debt Reduction and LiquidityCRA ended the quarter with $129.6 million of net debt after making $69 million of net payments to reduce borrowings. Total liquidity was $192.3 million, consisting of $20.4 million in cash and cash equivalents and $171.9 million of available credit capacity.
  • Increased Dividend and Shareholder ReturnsCRA increased its quarterly cash dividend 17.5%, from $0.57 to $0.67 per common share. This was the tenth consecutive annual dividend increase. Year-to-date, CRA returned $60.3 million to shareholders, including $11 million of dividends and $49.3 million for repurchases of approximately 309,000 shares at an average price of $160 per share.
  • Continued Talent and Growth InvestmentManagement said noncash forgivable loan amortization is expected to increase by approximately $15 million in fiscal 2026, reflecting investments in talent to drive value-creating growth. Third-quarter net cash outlays included $0.5 million for talent investments.
  • AI Adoption and Preventative Services OpportunityCRA uses AI tools on almost all engagements to help with delivery, and Forensic Services is seeking to expand from incident-response work into preventative services. Management said AI has increased complexity and has amplified demand related to the number of global breaches, while CRA continues to apply its AI governance model.

DE:CR2 Earnings History

DE:CR2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)2.01-1.85――
Nov 05, 20262026 (Q3)1.861.961.856.31% (+0.12)
Aug 06, 20262026 (Q2)1.921.941.6914.89% (+0.25)
May 07, 20262026 (Q1)1.811.781.99-10.36% (-0.21)
Feb 26, 20262025 (Q4)1.851.851.821.48% (+0.03)
Oct 30, 20252025 (Q3)1.621.851.5916.38% (+0.26)
Jul 31, 20252025 (Q2)1.651.691.642.73% (+0.04)
May 01, 20252025 (Q1)1.751.991.7613.27% (+0.23)
Feb 20, 20252024 (Q4)1.451.821.4624.54% (+0.36)
Oct 31, 20242024 (Q3)1.421.591.0156.64% (+0.57)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed